Prognostic scores used to predict post operative outcomes in patients with chronic liver disease
| Score | Components | |||
| Child-Turcotte-Pugh (CTP) | Score | 1 | 2 | 3 |
| Albumin (g/L) | >35 | 28–35 | <28 | |
| Bilirubin(μmol/L) | <34 | 34–50 | >50 | |
| Clotting (INR) | <1.7 | 1.7–2.2 | >2.2 | |
| Ascites | None | Diuretic responsive | Diuretic resistant | |
| Encephalopathy | None | Grade 1 or 2 | Grade 3 or 4 | |
| Class | A | B | C | |
| Total score | 5–6 | 7–9 | 10–15 | |
| Model for End-Stage Liver Disease (MELD) | Creatinine (μmol/L) | |||
| Bilirubin (μmol/L) | ||||
| Clotting (INR) | ||||
| Dialysis at least twice in past week | ||||
| Formula = (0.957 x ln (Serum Cr) + 0.378 x ln (serum Bilirubin) + 1.120 x ln (INR)+0.643) x 10 (if haemodialysis, value for creatinine is automatically set to 4.0) | ||||
| ASA | ASA I—Normal healthy patient | |||
| ASA II—Patient with mild systemic disease | ||||
| ASA III—Patient severe systemic disease that is not a constant threat to life | ||||
| ASA IV—Patient with severe systemic disease that is a constant threat to life | ||||
| ASA V—Moribund patient not expected to survive with or without surgery | ||||
| ADOPT-LC | Age (years) | |||
| Charlson Comorbidity index | ||||
| CTP Class | ||||
| Anaesthesia duration | ||||
| Mayo Postoperative Mortality Risk Score (https://www.mayoclinic.org/medical-professionals/transplant-medicine/calculators/post-operative-mortality-risk-in-patients-with-cirrhosis/itt-20434721) | Age | |||
| ASA Score | ||||
| Bilirubin (mg/dL) | ||||
| Creatinine (mg/dL) | ||||
| INR | ||||
| Aetiology of cirrhosis | ||||
| VOCAL-Penn (https://www.vocalpennscore.com/) | Age (Years) | BMI >30 | ||
| Albumin (g/L) | NAFLD aetiology | |||
| Bilirubin (μmol/L) | ASA score | |||
| Platelet count (×109/L) | Emergency surgery | |||
| Surgery type | ||||
ADOPT-LC, Adequate Operative Treatment for Liver Cirrhosis; ASA, American Society of Anesthesiologists; BMI, body mass index; INR, international normalised ratio; NAFLD, non-alcoholic fatty liver disease.